Clinical Trial Update: Managing Opioid Related Sleep Apnea With Acetazolamide [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update from University of California, San Diego evaluating acetazolamide to manage opioid-related sleep apnea. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Sleep Apnea
• Obstructive Sleep Apnea

Drugs mentioned

• ACETAZOLAMIDE (acetazolamide)

Snippet

Sponsor: University of California, San Diego | Conditions: Sleep-Disordered Breathing, Obstructive Sleep Apnea | Phase 2 | Status: COMPLETED